Skip to main content
TipRanks
Go Ultimate75% OFF

Oruka Therapeutics (ORKA) Drug Pipeline

858 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Orka-002Hidradenitis Suppurativa (Hs)Phase IIRecruitingORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis SuppurativaAug 20, 2026―
Orka-002Plaque PsoriasisPhase IIRecruitingDose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque PsoriasisMar 11, 2026
Orka-001Plaque PsoriasisPhase IIRecruitingAn Open-Label Extension Study of ORKA-001 in Participants With Plaque PsoriasisFeb 26, 2026
Orka-001Plaque PsoriasisPhase IIRecruitingDose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque PsoriasisDec 16, 2025
Orka-001 Induction Dose, Orka-001 Maintenance DosePlaque PsoriasisPhase IIActive Not RecruitingORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque PsoriasisJul 21, 2025
Orka-002Healthy VolunteersPhase IActive Not RecruitingORKA-002-211 A Phase I Study to Evaluate ORKA-002 in Healthy Volunteers Following A Single DoseApr 15, 2025―
Orka-001Healthy VolunteersPhase ICompletedORKA-001 in Healthy VolunteersNov 13, 2024

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Oruka Therapeutics, Inc. (ORKA) have in its pipeline
Oruka Therapeutics ORKA is currently developing the following drugs: Orka-002, Orka-001, Orka-001 Induction Dose, Orka-001 Maintenance Dose. These drug candidates are in various stages of clinical development as the company works toward FDA approval.